论文部分内容阅读
糖尿病患者冠心病的发病率是非糖尿病患者的3-4倍,冠脉介入性治疗(percutaneous coronary intervention,PCI)因其痛苦少、恢复快、效果好,同时又可避免传统开胸手术造成的巨大创伤,故已成为治疗冠心病合并糖尿病患者的首选方案。
The incidence of coronary heart disease in patients with diabetes is 3-4 times higher than that in non-diabetic patients. Percutaneous coronary intervention (PCI) is less painful, faster to recover and effective and can avoid the huge cost caused by traditional thoracotomy Trauma, it has become the treatment of coronary heart disease patients with diabetes preferred solution.